The FDA approved the first epinephrine nasal spray, Neffy, for the emergency treatment of allergic reactions, including anaphylaxis. This needle-free alternative can be used in children and adults weighing at least 66 pounds. Anaphylaxis is a life-threatening allergic reaction that requires immediate medical attention. Neffy provides a simpler alternative to traditional epinephrine injections, with comparable effectiveness in increasing blood pressure and heart rate. Individuals with specific nasal conditions should consult a healthcare professional before using Neffy. Expected side effects include throat irritation, nasal discomfort, and headache. The approval of Neffy offers a needle-free, easy-to-carry option for treating severe allergies and anaphylaxis.
Source link
Know All About First FDA Approved Nasal Spray To Treat Severe Allergic Reactions
